DRTECH Corporation
Financials
Valuation Metrics
DRTECH Corporation's Market Cap is ₩688B. At end of 2025 it was ₩1757B. Ranked #1506 of 2,436 in KR market (top 62%), #867 of 1,649 on KOSDAQ (top 53%), #58 of 96 in Health Care Equipment & Services (top 60%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 68.79B KRW | KR#1,506/2,436 Sec#58/96 |
| Revenue | 122.78B KRW | KR#1,282/2,436 Sec#22/96 |
| Net Income | -20.52B KRW | KR—/2,436 Sec—/96 |
| Total Assets | 205.11B KRW | KR#1,261/2,436 Sec#33/96 |
| Net Assets | 76.20B KRW | KR#1,592/2,436 Sec#47/96 |
| Employees | 367 | KR#654/2,436 Sec#15/96 |
| Value | ||
| P/B | 0.90x | KR#1,392/2,436 Sec#32/96 |
| P/S | 0.56x | KR#1,018/2,436 Sec#10/96 |
| FCF Yield | -38.68% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | -26.93% | KR#2,139/2,436 Sec#75/96 |
| ROA | -10.01% | KR#2,074/2,436 Sec#68/96 |
| Op. Margin | -8.93% | KR#1,959/2,436 Sec#62/96 |
| Revenue Growth | 25.53% | KR#538/2,436 Sec#22/96 |
| Financial Health | ||
| Debt Ratio | 269.16% | KR#2,062/2,436 Sec#87/96 |
| Total Debt | 94.21B KRW | KR#737/2,436 Sec#16/96 |
| FCF | -26.61B KRW | KR#1,968/2,436 Sec#76/96 |
| Cash | 13.33B KRW | KR#1,497/2,436 Sec#52/96 |
| Current Ratio | 1.70x | KR#1,143/2,436 Sec#60/96 |
| Dividend | ||
| Div. Yield | 0.00% | KR#1,391/2,436 Sec#40/96 |
| Div. Growth | 0.00% | KR—/2,436 Sec—/96 |
| Performance | ||
| 1Y Return | -49.91% | KR#2,077/2,436 Sec#76/96 |
| 1M Return | -23.13% | KR#2,271/2,436 Sec#90/96 |
| From 52W High | -65.16% | KR#1,962/2,436 Sec#68/96 |
| 1Y MDD | -68.35% | KR#1,874/2,436 Sec#66/96 |
| Trading | ||
| Volume | 79,327 shares | KR#1,071/2,436 Sec#44/96 |
| Foreign Own. | 2.12% | KR#1,079/2,436 Sec#40/96 |
| Per Share | ||
| EPS | -250 KRW | KR—/2,436 Sec—/96 |
| BPS | 861 KRW | KR#2,314/2,436 Sec#89/96 |
Company Info
DRTECH, established in 2000 and listed on KOSDAQ in 2016, is a digital diagnostic imaging solution company. Leveraging over 20 years of imaging diagnosis technology, it uniquely offers total solutions encompassing all X-ray systems and components, integrating system, software, and detector into a unified platform. The company maintains global operations with approximately 80% of its sales from overseas and is expanding its market influence with digital mammography upgrade solutions and a full product lineup. DRTECH is headquartered in Seongnam-si, Gyeonggi-do.